Top Companies in North America Injection Pen Market with Market Size | Suppliers 2025

Top Companies in North America Injection Pen Market with Market Size

North America Injection Pen Market has witnessed significant growth as leading companies have been at the forefront of developing innovative injection pen technologies that cater to the specific needs of patients. Apart from this, introduced a wide range of injection pen devices designed to enhance glycaemic management, improve therapeutic outcomes, and empower individuals in managing their health conditions. Additionally, focus on patient-centricity, product differentiation, and technological advancements. Market leaders are investing heavily in research and development to introduce features such as smart sensors, Bluetooth connectivity, and dose memory functions, which enable patients to monitor and track their medication usage more effectively.

As the demand for injection pens continues to surge, the North America market is expected to experience significant growth in the coming years. Factors such as an aging population, increasing healthcare expenditure, and the need for better self-care options are driving the market expansion. Moreover, ongoing advancements in injection pen technologies and the introduction of novel therapies are set to further propel the market, offering patients a brighter future in managing their health conditions with greater convenience and precision. As per 6Wresearch, North America Injection Pen Market is projected to grow at a significant CAGR of 8.2% from 2025-2031.

List of the Leading Companies in the North America Injection Pen Market

1. Novo Nordisk

Novo Nordisk is a globally recognized leader in diabetes care and chronic disease management. The company is known for its state-of-the-art insulin delivery solutions, including the FlexPen and NovoPen, which are designed for ease of use, accurate dosing, and improved patient adherence. With a strong focus on research and development, Novo Nordisk continues to innovate in diabetes treatment and injection pen technology.

2. Sanofi

Sanofi is a multinational pharmaceutical company specializing in diabetes, oncology, immunology, and other therapeutic areas. Its SoloStar pens are widely used for insulin delivery, offering precision dosing and an easy-to-use design. Sanofi is committed to advancing innovative solutions that improve patient outcomes while ensuring accessibility and convenience in chronic disease management.

3. Eli Lilly and Company

Eli Lilly is one of the pioneers in diabetes care, developing innovative treatment options and user-friendly insulin delivery devices. The company’s injection pens, such as the KwikPen and Tempo Pen, prioritize comfort, ease of use, and effective insulin administration. With a legacy of over a century, Eli Lilly remains at the forefront of diabetes treatment, continuously improving its injectable solutions.

4. Novo Nordisk Distribution in North America

Novo Nordisk's North American division ensures widespread accessibility to its innovative diabetes care solutions, including cutting-edge injection pen technologies. This regional arm is dedicated to providing patients and healthcare providers with high-quality, reliable treatment options, supporting better chronic disease management while maintaining a strong research and support infrastructure.

5. Medtronic

Medtronic is a global leader in medical technology, specializing in devices for diabetes management and other chronic conditions. Its injection pen solutions integrate advanced mechanics with digital health technologies, allowing for precise dosing and improved patient adherence. Medtronic is at the forefront of developing intelligent drug delivery systems that enhance the quality of life for patients worldwide.

6. Becton, Dickinson and Company (BD)

BD is a leading global medical technology company that develops precision-engineered injection devices, including pen needles and advanced drug delivery systems. Known for its commitment to safety and innovation, BD enhances the effectiveness of injectable therapies by improving comfort, minimizing pain, and ensuring precise medication administration for diabetes and other chronic diseases.

7. Ypsomed

Ypsomed specializes in the development and manufacturing of self-injection devices, offering innovative and customizable solutions for pharmaceutical companies. Their flagship products, including the YpsoPen, focus on patient-friendly design, ease of use, and high precision in drug delivery. Ypsomed is a trusted partner in the diabetes and biopharmaceutical sectors, providing cutting-edge solutions that enhance treatment adherence.

8. Terumo Corporation

Terumo Corporation is a leading Japanese medical technology company known for its precision-engineered injection solutions. The company’s Nanopass 34 pen needles are among the thinnest available, reducing injection pain while ensuring effective drug delivery. Terumo is dedicated to advancing patient care by continuously innovating in the field of injectable therapies.

9. F. Hoffmann-La Roche Ltd.

Roche is a global healthcare leader with a strong presence in diabetes management. The company’s Accu-Chek insulin delivery systems, including user-friendly injection pens, help patients achieve better glycemic control. Roche’s focus on digital health integration and precision medicine continues to drive advancements in diabetes care.

10. Owen Mumford

Owen Mumford is a leading manufacturer of innovative injection pen devices, specializing in ergonomic and user-friendly designs. Its AutoPen series is widely used for insulin administration, offering precise dosing and improved patient comfort. The company remains committed to designing high-quality medical devices that enhance treatment efficiency and ease of use for patients and healthcare professionals alike.

Frequently Asked Questions About the Market Study (FAQs):